Metabolomics and Integrative Omics for the Development of Thai Traditional Medicine
- 1Center of Applied Thai Traditional Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- 2Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
- 3Systems and Synthetic Biology, Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
- 4Department of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States
- 5Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
In recent years, interest in studies of traditional medicine in Asian and African countries has gradually increased due to its potential to complement modern medicine. In this review, we provide an overview of Thai traditional medicine (TTM) current development, and ongoing research activities of TTM related to metabolomics. This review will also focus on three important elements of systems biology analysis of TTM including analytical techniques, statistical approaches and bioinformatics tools for handling and analyzing untargeted metabolomics data. The main objective of this data analysis is to gain a comprehensive understanding of the system wide effects that TTM has on individuals. Furthermore, potential applications of metabolomics and systems medicine in TTM will also be discussed.
Literature search procedure that we used to produce this manuscript is described below. The PubMed, Google Scholar, Web of Science database were searched with the terms of “metabolomics,” “traditional Thai medicine,” “metabolome analysis,” “herbal medicine” or “analytical chemistry,” “integrative data analysis” or “omic analysis” or “univariate analysis” or “multivariate analysis” or “omics in Chinese herbal medicine”. Search criteria were included original research articles, review articles, books, national reports that were published in English language only.
Thai Traditional Medicine (TTM)
Traditionally, Thai traditional medicine (TTM) is defined as a holistic medicine that comprises both methods and practices. The TTM is heavily influenced by Buddhism. According to this religious belief, the human body is composed of four elements: earth, water, wind and fire, and an imbalance in one of these elements will lead to illness (Chokevivat and Chuthaputti, 2005). TTM consists of four different aspects: medical practice (diagnosis and treatment), pharmacy practice (the production and the use of herbal medicines), traditional midwifery and traditional Thai massage (Akarasereenont et al., 2015). A number of theories and hypotheses used in TTM have accumulated from several eras including Sukhothai to Ayutthaya (1350–1767), Thonburi (1767–1782) and the early period of Rattanakosin (Bangkok) in 1782–1851 (Chuthaputti and Boonterm, 2010). This knowledge was built based on the historical experiences, traditional wisdom, and ancient medical textbooks that were passed down and developed by each generation to practictioners. To promote TTM in the national healthcare system, the Thai government has continued to fully support TTM research, particularly since 1997 in the area of medicinal plants. This national strategic plan resulted in widespread research on herbal medicines, with most of the research being focused on the preclinical study of single herbs. This action has led to the development of several databases of herbal medicine such as, Medplant online (http://www.medplant.mahidol.ac.th) by the Faculty of Pharmacy at Mahidol University, and Thaicrudedrug (http://www.thaicrudedrug.com) by the Faculty of Pharmaceutical Sciences at Ubon Ratchathani University.
Although research and development efforts involving TTM have continued to increase, the use of herbal medicines for the treatment of illnesses in Thailand is relatively low compared to modern medicine. This is mostly due to the lack of clinical evidence, especially in the aspect of efficacy and safety of the various herbal medicines. Therefore, additional effort is needed for the deep investigation of herbal medicines at both molecular and phenotypic levels.
The advent of high-throughput technology known as “omics” has proven to be very useful across multiple areas of biology. Among these, metabolomics has shown to be a promising tool to describe the phenotypes in a dynamic context. Metabolomics is the area of study that seeks to identify and quantify the complete set of metabolites in a given organism (Nicholson et al., 1999; Fiehn, 2001). Typically, metabolites are defined as small molecules (<1 kDa) that are intermediates or products of metabolic reactions (Holmes et al., 2008). Metabolome analysis normally consists of a series of several steps that include sample preparation, measurement and data analysis (Villas-Bôas et al., 2006; Mushtaq et al., 2014). In metabolomics, quenching is a process used to stop metabolite turnover, especially during the sampling and sample preparation steps. The process is highly effective for most of the primary metabolites such as, amino acids, sugars, organic acids or carbohydrates. Secondary metabolites, on the other hand, which include a group of metabolites that are derived from three families such as, phenolics, alkaloids, and terpenes and steroids (Bourgaud et al., 2001), typically have a much slower turnover rate and are more chemically stable than primary metabolites, elminating the need to quench during sample preparation. These latter groups of metabolites are often of more interest for use in traditional medicine (Kennedy and Wightman, 2011). After quenching, samples are extracted, which typically involves a wide range of organic or inorganic solvents such as, methanol (Kanchanapoom et al., 2001; Nakamura et al., 2008; Sawasdee et al., 2009; Tripatara et al., 2012; Padumanonda et al., 2014), ethanol (Sutthanut et al., 2007; Thiengsusuk et al., 2013), ethyl acetate (Shimokawa et al., 2013), or hexane (Lu et al., 2009) depending upon the metabolites of interest. There are numerous extraction methods available, e.g., classical solvent extraction, steam extraction, supercritical fluids extraction, microwave-assisted extraction, subcritical water extraction or high hydrostatic pressure extraction (Starmans and Nijhuis, 1996; Stalikas, 2007; Zhang et al., 2011; Khoddami et al., 2013; Khoomrung et al., 2013). These methods often allow for the addition of internal standards (ISs) at the beginning of the extraction step to enable, e.g., accurate quantification of the metabolite of interest, and normalization against technical variability or other experimental variations. Furthermore, the addition of ISs is helpful for subsequently calculating the efficiency of extraction or purification of the clean-up methods. In addition to the extraction and quantification steps, the identification of metabolites is also a crucial step in metabolomics. This can be performed using two separate and complementary approaches: untargeted and targeted (Patti et al., 2012).
Untargeted analysis (Figure 1) aims to simultaneously detect as many metabolites as possible in a given sample. Liquid or gas chromatography (LC/GC) coupled with mass spectrometry (MS) and nuclear magnetic resonance (NMR) are often employed for this purpose (Wishart, 2016). Untargeted metabolomics relies heavily on the technology for the measurement of numerous features (metabolites) as well as bioinformatics tools to handle the dataset. With the latest advancements in MS technology, it is now possible to routinely detect more than 2000 features in a single run; however, data processing, data analysis and metabolite identification remains a big challenge of this approach.
Analyzing Untargeted MS-Based Metabolomics Data
The ultimate goals of metabolomics data analysis are quantification and identification of compounds in the sample. The typical output from GC-MS and LC-MS are the chromatograms representing the amounts of detected compound(s), and mass spectra representing the fingerprint of the compound. Ideally, a chromatogram represents the amount of an individual compound. However, in many situations, co-elution of more than one compound is often encountered. Deconvolution (Colby, 1992) can be applied, which uses an algorithm to discriminate a desired signal from raw data. This is particularly useful when the desired signal has been contaminated by other interferences. This process can be performed using commercial software from different vendors such as, Agilent technologies, ThermoFisher, Waters Corporation, or from a research institution such as, the National Institute of Standards and Technology (NIST). Typically, the algorithm detects peaks by calculating signal to noise ratios, then performs calibrations using data from chromatograms and m/z aligment (Niu et al., 2014) to obtain confidence features and their intensity. Normalization and scaling are the next two steps to make data comparable across different samples.
Usually, a single IS or mix of ISs are used as a control to counter the unwanted variations which may occur during experimental measurements. It has been shown that statistical models utilizing multiple ISs for normalization often provide more robust results as compared to the use of a single IS (Redestig et al., 2009; Risso et al., 2014). Sysi-Aho et al. (2007) introduced a normalization method called normalization using optimal selection of multiple ISs (NOMIS) (Sysi-Aho et al., 2007). This method employs multiple ISs to estimate the optimal value for normalization of an individual feature in the chromatogram. Furthermore, both supervised and unsupervised approaches can be applied in the NOMIS algorithm. In 2009, Redestig and co-workers introduced a method called cross-contribution compensating multiple standard normalization (CCMN) (Redestig et al., 2009). This CCMN method was built on a supervised statistical model and aimed to capture the influence of all metabolites in the sample based on the signal of ISs. The method follows the concept of cross-contribution and uses the model to correct the unwanted variation. In De Livera et al. (2015) proposed a normalization method based on a linear mixed effects modeling approach. This algorithm performed well by being able to reduce a greater number of unwanted variations from datasets as compared to other methods such as, NOMIS or CCMN. A great attribute of all aforementioned algorithms here is that they have been implemented as packages in R suite software, which is freely available for researchers.
The next step in metabolomics data analysis is to find important features such as, significant metabolomic differences comparing between experimental conditions. A univariate analysis such as, the parametric Student's t-test, ANOVA or non-parametric Mann-Witney U-test is typically the first method of choices for the standard analysis. Multiple testing corrections such as, false discovery rate (FDR) can then be performed to balance the number of false positives and false negatives. When performing a univariate analysis, the most common output for results will be in the form of fold changes and p-values (adjusted-p-values). These results can be used to further evaluate the identities of significant features in the considered dataset. In untargeted metabolomics, it is common for more than two variables or features (e.g., metabolite identity, peak intensity, retention times or mass spectra) to be simultaneously measured in one sample. Therefore, multivariate analysis is used for capturing possible relationships between individual variables. Two well-known methods that have been used extensively are principal component analysis (PCA) and partial least square analysis (PLS). PCA (Wold et al., 1987) is an unsupervised method that is often used to evaluate intrinsic variability among the observations (samples). PCA is a dimensional reduction method that employs covariances of a dataset to transform the data to a new coordinate system, enabling one to distinguish which factors contribute most to the variability in the data. Mathematically, the number of principal components will be equal to the number of original samples. In PCA, the 1st component captures the largest possible amount of variance in the data, whereas the 2nd component describes the next-largest variation in a direction that is orthogonal to the 1st component. Unlike PCA, PLS is a supervised method that needs to have defined categorical variables. PLS applies multiple linear regression models by projecting measured variables to the categorical variables in a new space. The PLS model can further be used for discriminatory analysis referred to as PLS-DA (partial least square discriminant analysis). Typically, a PLS-DA model is formulated from the separation planes between classes (more than a 1-dimensional plane), leading to class-specific information being given by the PLS-DA model (Bylesjo et al., 2006). In Trygg and Wold (2002) proposed an extension of PLS-DA model by incorporating an orthogonal signal correction method which was previously proposed by Wold et al. (1998) called OPLS-DA (orthogonal partial least square discriminant analysis). Incorporation of orthogonal signal correction into PLS maximizes the explained covariance in the model, leading to improved discrimination among classes when compared with PLS-DA. Both PLS-DA and OPLS-DA can be performed in SIMCA (Soft Independent Modeling of Class Analogies) software (Bylesjo et al., 2006) or freeware under R suite environment (Thevenot et al., 2015). Multivariate analysis approaches are comprehensively reviewed by Worley et al. (Worley and Powers, 2013) and have been applied to various metabolomic studies, including the analysis of plant metabolomics (Madala et al., 2014; Hagel et al., 2015), plasma and serum metabolomics (Barri and Dragsted, 2013), and metabolomic data of lung cancer tissues (Wikoff et al., 2015).
Targeted metabolomics relies heavily on analytical chemistry, and typically involves the measurement of specific metabolites of interest, or for confirmation of results from an untargeted analysis. Traditionally, the targeted approach (Figure 2) begins with the evaluation of the analytical performance of the detection method (instrument) such as, specificity, linearity, sensitivity, limit of detection, limit of quantification, accuracy, and precision. Typically, evaluating the performance of these parameters is performed using authentic standards. Once the detection method has been implemented, the analytical protocol (including sample preparation) should be validated. Validation of the analytical protocol is normally accomplished by using a standard reference material (Khoomrung et al., 2012, 2014; Phinney et al., 2013) (if available) or a spiking experiment to estimate the overall recovery of the protocol (Khoomrung et al., 2013). After validation of the analytical procedure, the method is then applied to quantify metabolites in the real samples of interest.
Once the significant features have been identified from statistical methods, the next critical step is to determine their identity. This step is particularly challenging for untargeted metabolomics where metabolic identification is the largest bottleneck for acquiring new biological knowledge from the given study. Putative identification of the significant features obtained by MS are normally performed based on an accurate measurement of the mass-to-charge (m/z) ratio to define the molecular formula. Normally, mass spectra and/or retention time will be searched against MS libraries through databases; for example, metlin, lipidmaps, HMDB, or massbank (Tautenhahn et al., 2012), to identify possible compound name(s) for the queried MS peaks. The two problems most often encountered are either there are no hits, or multiple hits are found. The putatively identified metabolites are subsequently confirmed with an MS/MS experiment, by comparing their mass spectra and retention time with the authentic standards or an independent targeted experiment (Section Targeted Metabolomics). Even though metabolite identification remains a major challenge in untargeted metabolomics, there exists a wide variety of metabolome databases to assist with this process. The recent review by Fukushima and Kusano (2013) summarized a wide range of metabolome databases, which include mass spectrum-oriented databases for metabolite identification; compound-oriented databases for chemical information; metabolite-profile databases for compound information; and pathway-oriented databases for compound annotation in the context of metabolic pathways (Fukushima and Kusano, 2013). Further information on the strategies, approaches, and tools used for metabolite identification are beyond the scope of this review, and have been covered in greater detail by Dunn et al. (2013), Fukushima and Kusano (2013) and Vinaixa et al. (2016).
Integrative Omics Data Analysis for TTM
Single omics has until now been the predominant form of global data acquisition and analysis, with transcriptomics being one of the most mature and commonly studied omics (Ma et al., 2001; Wang et al., 2017; Yin et al., 2017). Transcriptomics provides a snapshot of mRNA profiles within a specific context, and is increasingly used in Chinese medicine research to characterize physiology, regulatory mechanisms and metabolisms of Chinese medicinal herbs, as reviewed in Lo et al. (2012). Another common omics method, proteomics, involves the quantification of proteins, protein post-translational modifications, and protein interactions. For instance, in the area of herbal medicine, proteomics has been used to investigate the mechanism of action of a Chinese herb, Salvia miltiorrhiza (Hung et al., 2010) and abundance of Ginseng peptides (Ye et al., 2016). Metabolomics data provide the comprehensive profiling of metabolites in a system under consideration. Typically metabolites, along with proteins, are the molecular components that ultimately carry out the cellular functions encoded by the genome. Hence metabolite levels can be considered as the most reflective of biological systems to any perturbations. There are a number of studies employing metabolite profiles to describe molecular mechanisms of medicinal plants (Fukuhara et al., 2011; Liu et al., 2013; Zhang et al., 2013; Le et al., 2016; Jiang et al., 2017). Additionally, metabolomics has been applied for drug discovery, pharmacokinetic analyses, pharmacodynamics investigations, evaluation of toxicity and toxic mechanisms of compounds in phamaceutical research (Zhang et al., 2014; Su et al., 2016; Cui et al., 2017; Kantae et al., 2017; Li et al., 2017). The emergence of metabolomics has enabled this type of data to be integrated with other omics types (genomics, transcriptomics, epigenomics, and proteomics) to gain a more comprehensive understanding of biological systems under study. However, translation of these omics data into biologically meaningful knowledge is still progressing and requires the development of more advanced computational and statistical methods. Currently, there exist several approaches for the integrative analysis of omic data which can potentially be applied to TTM. For example, in plant research, genome-scale metabolic models have been exploited in conjunction with metabolomics and transcriptomics to examine characteristics of metabolic networks, unravel metabolic phenotypes and further guide genetic engineering (Fukushima et al., 2014; Lakshmanan et al., 2015, 2016; de Oliveira Dal'Molin et al., 2016). Furthermore, a systems biology-based approach has been used to elucidate mechanisms of traditional Chinese medicinal formulas in specific diseases (Huang et al., 2015; Zhao et al., 2017).
Conceptually, methods which aim to integrate multi-omic data can be divided into two approaches: horizontal and vertical integration (Tseng et al., 2012). Horizontal data integration has been used extensively over recent years for microarray meta-analysis. This method combines a single level of omic data sets (e.g., transcriptomics) which are under similar conditions (Marot et al., 2009; Shen and Tseng, 2010; Tseng et al., 2012; Xia et al., 2013). Meanwhile, vertical data integration assimilates multi-level omic data sets (e.g., integration of transcriptomics and metabolomics) and is the predominant method used in systems biology to integrate data (Xia et al., 2013). The concept of vertical data integration is the main focus of this part of the review. A number of computational- and statistical-based approaches for vertical integrative analysis include empirical correlation-based analysis (CBA) (Wanichthanarak et al., 2015; Cavill et al., 2016), pathway- or ontology-based analysis (Wanichthanarak et al., 2015; Cavill et al., 2016), network-based analysis (Fukushima et al., 2014; Wanichthanarak et al., 2015) and machine learning approaches (Li and Ngom, 2015).
For CBA, the primary aim is to find correlative links between data sets, such as, omic data and clinical data. In addition, CBA is useful for the analysis of unannotated metabolites from an untargeted analysis, since it has a limited number of biochemical domains or pathway information (Grapov et al., 2015). An effort to calculate a weighted correlation network of human blood metabolomics and transcriptomics has been demonstrated by Bartel et al. (2015). By creating this network, the authors were able to show that pairs of strongly correlated metabolites and transcripts biologically relate in terms of regulatory signaling and transport mechanisms. Pathway- or ontology-based analyses are one of the most commonly used methods for biological interpretations of omic data. It reduces data complexity by grouping related metabolites or genes based on pathways or biological functions before calculating enrichment statistics (Khatri et al., 2012). For example, a tool such as, IMPaLA (Integrated Molecular Pathway Level Analysis) improves identification of pathways through enrichment or overrepresentation analysis by integrating lists of metabolites and genes (Kamburov et al., 2011). The current generation of pathway analysis approaches includes additional information such as, pathway topology (Khatri et al., 2012; Li et al., 2013; Ihnatova and Budinska, 2015) and expression correlations (Feng et al., 2016) to enhance specificity, sensitivity and accuracy of pathway identification. From a network of molecular interactions, network-based analysis infers biological information from topological measures (such as, closeness centrality, degree distribution, degree centrality, betweenness centrality, and clustering coefficient (Winterbach et al., 2013). These biological networks can also serve as a scaffold for the integration of multiple omic datasets to identify active subgraphs, and support other visual analyses of omic data in the context of networks (Gerasch et al., 2014; Vehlow et al., 2015). A study by Fahrmann et al. uses a network derived from biochemical reactions and chemical structural similarity relationships to show metabolic alterations in type 1 diabetic and nondiabetic mice (Fahrmann et al., 2015). Machine learning approaches (such as, support vector machines, decision tree, Bayesian classifier, and neural networks) are capable of making predictive models and knowledge discovery by integrating data sets from several sources or multiple levels (Li and Ngom, 2015). Rajasundaram et al. (Rajasundaram and Selbig, 2016) summarized that integrative data analysis is often used for examining underlying relationships between omic datasets and for increasing predictive accuracy by using information from one or more datasets. One challenge of data integration is the heterogeneity of the different omics data. This can be considerably challenging for data-driven strategies, nonetheless applications of such methods are being increasingly reported in this big data era in various disciplines, such as, plant science (Bassel et al., 2011; Ma et al., 2014), chemoinformatics (Mitchell, 2014), drug discovery (Lavecchia, 2015), and medicine and health (Andreu-Perez et al., 2015; Kourou et al., 2015; Swan et al., 2015; Hao et al., 2016). It can therefore be seen that these methods can be successfully applied to study the properties and impacts of TTM. By intergating different omics as well as clinical data (both in vitro and in vivo experiments) for the study of TTM (Figure 3), it will therefore be possible to accelerate the development of TTM in several aspects such as, drug discovery and development, and medical treatment.
Figure 3. Integration of multi-omics and clinical data into TTM. (A) Herbal plants and herbal medicines. (B) Chemical characterization of herbal plants, herbal medicines, and biofluids using targeted and untargeted metabolomics. (C) Clinical trial of herbal plants and herbal medicines by cell lines, animal, or human models. (D) Biofluid for metabolome analysis. (E) Integrative analysis of different omics data and clinical data. (F) Systems biology network. (G) Individualized data.
Current Metabolomics Activities Related to TTM
Metabolomics is a relatively new approach to the field of TTM, with only targeted approaches having been performed so far, particularly in the area of herbal plants. Most of the analyses have focused on searching for novel or known bioactive compounds from herbal plants. In many cases, the analysis of metabolites from the herbal plants was performed without a quenching step. The traditional liquid extraction remains the most popular method and is widely used in herbal plant research because of simplicity, easy to develop protocal, universal application, and relatively low cost. Sutthanut et al. (2007) employed ethanol (95%, v/v) to extract flavonoids from Kaempferia parviflora (Krachaidum). The rhizomes of Krachaidum have been widely used in TTM, especially for the treatment of health, promoting anti-inflammatory activity (Yenjai et al., 2004) or gastrointestinal disorders (Jaipetch et al., 1983). In 2014, Padumnonda and co-workers (Padumanonda et al., 2014) also reported the use of methanol to extract melatonin (N-acetyl-5-methoxytryptamine) from seven herbs. The seven samples used in this study were Piper nigrum L, Sesbania glandiflora (L.) Desv., Sesbania sesban (L.) Merr., Senna tora (L.) Roxb, Moringa oleifera Lam., Momordica charantia L. and Baccaurea ramiflora Lour. These herb samples are normally recommended for sleeping aids or treatment of insomnia.
In general, methanol and ethanol are the most widely used organic solvents for extraction of different metabolites from herbal plants, and the combination of methanol and water is also very attractive for many biological samples (Kanchanapoom et al., 2001; Villas-Bôas et al., 2006; Teo et al., 2011; Padumanonda et al., 2014). However, these extraction methods may not always provide relevant data for all cases in TTM, such as, in the case of water decoction (hot aqueous extract), whereby a liquid medicine is made from the extraction of multiple herbs in boiling water. After the medical preparation, only the liquid fraction is used as the medicine and administered to patients. The goal of metabolome analysis in this scenario is to chemically characterize metabolites present in the extract taken by the patients, rather than the entire set of metabolites contained within the herbs. In this case, water would be a more appropriate solvent for extraction as compared to methanol or ethanol. Furthermore, the downstream protocol used for the chemical analysis should be prepared as similarly as possible to the preparation process of the decoction medicine (glassware, time, and temperature). This will improve the accuracy of the metabolome information, and will greatly affect the overall outcome of the study. On the other hand, analysis of herbal medicines or herbal products can be even more complicated (Charoonratana et al., 2014). For example, many Thai medicines result from the mixture of different herbal material in various quantities to one another. These mixtures are ultimately manufactured in different forms; for example, in pill, capsule, or bolus form, and are consumed directly by the patient, without using an extraction step. However, the chemical compositions of these drugs are largely unknown, and a chemical analysis using a traditional extraction such as, a single solvent or two-phase solvent systems (e.g., methanol-water, methanol-chloroform) will yield an incomplete picture of the drug composition, especially if only one fraction is analyzed. This is therefore unlikely to provide sufficient information about all the possible metabolites that have been consumed by the patients, as there is no universal extraction method that can cover the entire spectrum of metabolites in a single extraction. In such cases, a good extraction protocol for chemical analysis of herbal medicines may include using more than just one solvent, or the extraction protocol can be performed more than once with different solvents (Yang et al., 2016). Increasing proportion of the organic solvents in the extraction process can lead to an increase in the number of extracted metabolites; however, this may require many additional sample clean-up steps prior to the measurements. In a previous study by the Nielsen group (Khoomrung et al., 2015), it was shown that the coverage of metabolites in a yeast sample can be increased (by 16%) when the analysis is performed on both polar and non-polar fractions as compared to the results from the polar-fraction alone. This approach could potentially be adopted to analyze the metabolome following treatment with herbal medicines. A study by Teo et al. (2011) demonstrated the use of multiple approaches for global metabolome analysis in Stevia rebaudiana and Coptidis rhizoma. The authors used methanol-water extraction and green-solvent microwave-assisted extraction (MAE) for the extraction of primary and secondary metabolites, and the subsequent isolated-extracted metabolites were monitored with GC-MS, 1H NMR and HPLC-UV techniques. Analysis of primary metabolites from the methanol fraction by GC-MS and 1H NMR in both samples showed the presence of the common polar and slightly non-polar metabolites such as, amino acids, sugars, organic acids, carbohydrates, and lipids. Analysis of the secondary metabolites by HPLC-UV after MAE extraction showed fewer metabolites e.g., stevioside, rebaudioside and berberine. The profiling of primary metabolites enabled a clear differentiation of sample origins, whereas metabolome data from secondary metabolites could not be used to distinguish samples from different sources.
In contrast to the targeted approach, the development and application of untargeted metabolomics in TTM is relatively unexplored. This is in part due to the relatively recent emergence of metabolomics, as well as the ongoing advancement of technologies such as, GC-MS, LC-MS, NMR, and the pace of advancement in bioinformatics for processing big data in the area of TTM. Nonetheless, due to the rapid evolution of these technologies and approaches, it is expected for progress to advance quickly in the early stages of development.
Potential Applications of Metabolomics to TTM
In the early stage of development, an application of metabolomics to TTM could potentially be seen in the area of medical and pharmacy practice. It is now widely accepted that metabolite levels are highly sensitive to environmental or physiological changes; thus, metabolomics could serve as an excellent tool to characterize metabolic profiles to help diagnose and treat patients. This could easily be accomplished through a minimally invasive, untargeted approach, e.g., analyzing body fluids such as, serum, plasma, urine, and saliva from subjects with different illnesses and comparing the results with healthy subjects. For example, the broad spectrum of detected features (metabolites) could aid the discovery of significant molecules contributing to particular diseases. Subsequently, such compounds can be validated using the targeted approach, which is more sensitive and accurate in determining both identity and quantity of a given metabolite. These strategies have been successful in the diagnosis of several diseases in modern medicine (Armitage and Barbas, 2014). Another promising application of metabolomics would be the use of targeted metabolomics to characterize chemical structures and components of bioactive compounds in herbal medicines, since one of the bottlenecks in herbal medicines is that most of the active components of the drugs are poorly defined. Furthermore, the constituents of these compounds can vary greatly from batch to batch, depending on several factors; for example, age of the plant, cultivation conditions (weather and season) or production process. In this context, the targeted metabolomics approach is particularly useful, by characterizing and defining the exact identities and concentrations of bioactive compounds contained within herbal material for each given product. This information would assist greatly in controlling the consistency of herbal medicine produced from different batches. Furthermore, understanding the chemical composition of herbal medicines provides an opportunity to elucidate their mechanism of action after taken by the patients. Untargeted metabolomics could be performed to profile metabolites from biofluids after the patients have taken the drugs, whereas targeted analysis will assist in the elucidation of metabolic processing of an individual drug. This information is particularly useful to aid the design and development of herbal medicine as well as to improve treatment and therapy in TTM.
The Establishment of a National Infrastructure to Improve TTM
At the Faculty of Medicine Siriraj Hospital, Mahidol University, we have been conducting research in several areas of systems biology and systems medicine such as, genomics, proteomics, metabolomics, and clinical research. To further increase research capacity, we have recently established the university metabolomics and phenomics platform, namely Siriraj Metabolomics and Phenomics Center (SiMPC) at Mahidol University. The aim of the SiMPC is to develop a top-level university platform for metabolomics and phenomics research. The center will conduct both research and service in the fields of metabolomics and phenomics as well as providing education and training to the students and researchers in Thailand. The scope of diseases and research topics will focus initially on diabetes mellitus, cancer, cardiovascular disease, dengue hemorrhagic fever, transplantation, and TTM. Using an integrated big data network at Siriraj Hospital, this will lead to the development of precision medicine and facilitate the translation of scientific knowledge into clinical practice for high impact diseases.
Conclusion and Perspectives
TTM is a holistic medicine with a long history of serving Thai society for many generations. Furthermore, TTM has remained a highly popular medical resource in Thailand for the Thai community; however, a major drawback of their use, until now, has been a lack of clinical evidence for what bioactive compounds they contain that mediate their therapeutic effects, and what their mechanism of action is within the patient. To promote the use of TTM in society, metabolomics can be utilized to identify chemical compositions, to screen for potentially active compounds in herbal plants or herbal medicines, as well as to evaluate the therapeutic effect of TTM during pre-clinical and clinical studies. Furthermore, integration of metabolomics and other omics will help to improve the overall understanding of the phenotypic characteristics of an individual subject, and will increase the rate of TTM development. Since metabolomics is relatively new to TTM, perhaps the greatest challenge in the early stages of development would be in implementing a measurement technology, such as, routine protocols for untargeted and targeted analysis, alongside the bioinformatics platform to handle the large dataset subsequently produced. Infrastructures, such as, SiMPC, will thus provide a promising contribution toward efforts to accelerate the development of TTM in the future.
This article does not contain any studies with human participants or animals performed by any of the authors.
SK, IN, and KW designed and drafted the manuscript. OT, PS, TL, and PA helped to draft the manuscript. SK, IN, KW, and PA made critical revisions to the final version. All authors reviewed and approved the final manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We would like to thank to Dr. Partho Sen, Dr. Eugene Fletcher, Dr. Kate Campbell, Dr. Jonathan Robinson and Prof. Jens Nielsen for comments and constructive discussions.
Akarasereenont, P., Datiles, M. J. R., Lumlerdkij, N., Yaakob, H., Prieto, J. M. M., and Heinrich, M. (2015). “A south-east asian perspective on ethnopharmacology,” in Ethnopharmacology, eds M. Heinrich and A. K. Jäger (Chennai: John Wiley & Sons Ltd), 317–329.
Barri, T., and Dragsted, L. O. (2013). UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Anal. Chim. Acta 768, 118–128. doi: 10.1016/j.aca.2013.01.015
Bartel, J., Krumsiek, J., Schramm, K., Adamski, J., Gieger, C., Herder, C., et al. (2015). The human blood metabolome-transcriptome interface. PLoS Genet. 11:e1005274. doi: 10.1371/journal.pgen.1005274
Bassel, G. W., Glaab, E., Marquez, J., Holdsworth, M. J., and Bacardit, J. (2011). Functional network construction in arabidopsis using rule-based machine learning on large-scale data sets. Plant Cell 23, 3101–3116. doi: 10.1105/tpc.111.088153
Bylesjo, M., Rantalainen, M., Cloarec, O., Nicholson, J. K., Holmes, E., and Trygg, J. (2006). OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J. Chemom. 20, 341–351. doi: 10.1002/cem.1006
Charoonratana, T., Songsak, T., Monton, C., Saingam, W., Bunluepuech, K., Suksaeree, J., et al. (2014). Quantitative analysis and formulation development of a traditional Thai antihypertensive herbal recipe. Phytochem. Rev. 13, 511–524. doi: 10.1007/s11101-014-9359-z
Chuthaputti, A., and Boonterm, B. (2010). “Traditional medicine in the Kingdom of Thailand: the integration of Thai traditional medicine in the national health care system of Thailand,” in Traditional Medicine in ASEAN (Bangkok: Medical Publisher), 97–120.
Cui, D. N., Wang, X., Chen, J. Q., Lv, B., Zhang, P., Zhang, W., et al. (2017). Quantitative evaluation of the compatibility effects of huangqin decoction on the treatment of irinotecan-induced gastrointestinal toxicity using untargeted metabolomics. Front. Pharmacol. 8:211. doi: 10.3389/fphar.2017.00211
De Livera, A. M., Sysi-Aho, M., Jacob, L., Gagnon-Bartsch, J. A., Castillo, S., Simpson, J. A., et al. (2015). Statistical methods for handling unwanted variation in metabolomics data. Anal. Chem. 87, 3606–3615. doi: 10.1021/ac502439y
de Oliveira Dal'Molin, C. G., Orellana, C., Gebbie, L., Steen, J., Hodson, M. P., Chrysanthopoulos, P., et al. (2016). Metabolic reconstruction of Setaria italica: a systems biology approadch for integrating tissue-specific omics and pathway analysis of bioenergy grasses. Front. Plant Sci. 7:1138. doi: 10.3389/fpls.2016.01138
Dunn, W. B., Erban, A., Weber, R. J. M., Creek, D. J., Brown, M., Breitling, R., et al. (2013). Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 9, 44–66. doi: 10.1007/s11306-012-0434-4
Fahrmann, J., Grapov, D., Yang, J., Hammock, B., Fiehn, O., Bell, G. I., et al. (2015). Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia. Am. J. Physiol. Endocrinol. Metab. 308, E978–E989. doi: 10.1152/ajpendo.00019.2015
Feng, C., Zhang, J., Li, X., Ai, B., Han, J., Wang, Q., et al. (2016). Subpathway-CorSP: identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways. Sci. Rep. 6:33262. doi: 10.1038/srep33262
Fukuhara, K., Ohno, A., Ando, Y., Yamoto, T., and Okuda, H. (2011). A 1H NMR-based metabolomics approach for mechanistic insight into acetaminophen-induced hepatotoxicity. Drug Metab. Pharmacokinet. 26, 399–406. doi: 10.2133/dmpk.DMPK-11-RG-005
Gerasch, A., Faber, D., Kuntzer, J., Niermann, P., Kohlbacher, O., Lenhof, H. P., et al. (2014). BiNA: a visual analytics tool for biological network data. PLoS ONE 9:e87397. doi: 10.1371/journal.pone.0087397
Grapov, D., Wanichthanarak, K., and Fiehn, O. (2015). MetaMapR: pathway independent metabolomic network analysis incorporating unknowns. Bioinformatics 31, 2757–2760. doi: 10.1093/bioinformatics/btv194
Hagel, J. M., Mandal, R., Han, B., Han, J., Dinsmore, D. R., Borchers, C. H., et al. (2015). Metabolome analysis of 20 taxonomically related benzylisoquinoline alkaloid-producing plants. BMC Plant Biol. 15:220. doi: 10.1186/s12870-015-0594-2
Hao, L., Greer, T., Page, D., Shi, Y., Vezina, C. M., Macoska, J. A., et al. (2016). In-depth characterization and validation of human urine metabolomes reveal novel metabolic signatures of lower urinary tract symptoms. Sci. Rep. 6:30869. doi: 10.1038/srep30869
Huang, L., Lv, Q., Liu, F., Shi, T., and Wen, C. (2015). A Systems biology-based investigation into the pharmacological mechanisms of Sheng-ma-bie-jia-tang acting on systemic lupus erythematosus by multi-level data integration. Sci. Rep. 5:16401. doi: 10.1038/srep16401
Hung, Y. C., Wang, P. W., and Pan, T. L. (2010). Functional proteomics reveal the effect of Salvia miltiorrhiza aqueous extract against vascular atherosclerotic lesions. Biochim. Biophys. Acta 1804, 1310–1321. doi: 10.1016/j.bbapap.2010.02.001
Jiang, W., Gao, L., Li, P., Kan, H., Qu, J., Men, L., et al. (2017). Metabonomics study of the therapeutic mechanism of fenugreek galactomannan on diabetic hyperglycemia in rats, by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1044–1045, 8–16. doi: 10.1016/j.jchromb.2016.12.039
Kamburov, A., Cavill, R., Ebbels, T. M., Herwig, R., and Keun, H. C. (2011). Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics 27, 2917–2918. doi: 10.1093/bioinformatics/btr499
Kanchanapoom, T., Kamel, M. S., Kasai, R., Picheansoonthon, C., Hiraga, Y., and Yamasaki, K. (2001). Benzoxazinoid glucosides from Acanthus ilicifolius. Phytochemistry 58, 637–640. doi: 10.1016/S0031-9422(01)00267-9
Kantae, V., Krekels, E. H., Esdonk, M. J., Lindenburg, P., Harms, A. C., Knibbe, C. A., et al. (2017). Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy. Metabolomics 13:9. doi: 10.1007/s11306-016-1143-1
Kennedy, D. O., and Wightman, E. L. (2011). Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv. Nutr. 2, 32–50. doi: 10.3945/an.110.000117
Khoomrung, S., Chumnanpuen, P., Jansa-ard, S., Nookaew, I., and Nielsen, J. (2012). Fast and accurate preparation fatty acid methyl esters by microwave-assisted derivatization in the yeast Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 94, 1637–1646. doi: 10.1007/s00253-012-4125-x
Khoomrung, S., Chumnanpuen, P., Jansa-Ard, S., Stahlman, M., Nookaew, I., Boren, J., et al. (2013). Rapid quantification of yeast lipid using microwave-assisted total lipid extraction and HPLC-CAD. Anal. Chem. 85, 4912–4919. doi: 10.1021/ac3032405
Khoomrung, S., Martinez, J. L., Tippmann, S., Jansa-Ard, S., Buffing, M. F., Nicastro, R., et al. (2015). Expanded metabolite coverage of Saccharomyces cerevisiae extract through improved chloroform/methanol extraction and tert-butyldimethylsilyl derivatization. Anal. Chem. Res. 6, 9–16. doi: 10.1016/j.ancr.2015.10.001
Khoomrung, S., Raber, G., Laoteng, K., and Francesconi, K. A. (2014). Identification and characterization of fish oil supplements based on fatty acid analysis combined with a hierarchical clustering algorithm. Eur. J. Lipid Sci. Technol. 116, 795–804. doi: 10.1002/ejlt.201300369
Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V., and Fotiadis, D. I. (2015). Machine learning applications in cancer prognosis and prediction. Comput. Struct. Biotechnol. J. 13, 8–17. doi: 10.1016/j.csbj.2014.11.005
Lakshmanan, M., Cheung, C. Y., Mohanty, B., and Lee, D. Y. (2016). Modeling rice metabolism: from elucidating environmental effects on cellular phenotype to guiding crop improvement. Front. Plant Sci. 7:1795. doi: 10.3389/fpls.2016.01795
Lakshmanan, M., Lim, S. H., Mohanty, B., Kim, J. K., Ha, S. H., and Lee, D. Y. (2015). Unraveling the light-specific metabolic and regulatory signatures of rice through combined in silico modeling and multiomics analysis. Plant Physiol. 169, 3002–3020. doi: 10.1104/pp.15.01379
Le, L., Jiang, B., Wan, W., Zhai, W., Xu, L., Hu, K., et al. (2016). Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity. Sci. Rep. 6:36184. doi: 10.1038/srep36184
Li, C., Han, J., Yao, Q., Zou, C., Xu, Y., Zhang, C., et al. (2013). Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. Nucleic Acids Res. 41:e101. doi: 10.1093/nar/gkt161
Li, C., Niu, M., Bai, Z., Zhang, C., Zhao, Y., Li, R., et al. (2017). Screening for main components associated with the idiosyncratic hepatotoxicity of a tonic herb, Polygonum multiflorum. Front. Med. 11, 253–265. doi: 10.1007/s11684-017-0508-9
Liu, X., Zhu, W., Guan, S., Feng, R., Zhang, H., Liu, Q., et al. (2013). Metabolomic analysis of anti-hypoxia and anti-anxiety effects of Fu Fang Jin jing oral liquid. PLoS ONE 8:e78281. doi: 10.1371/journal.pone.0078281
Lo, H. Y., Li, C. C., Huang, H. C., Lin, L. J., Hsiang, C. Y., and Ho, T. Y. (2012). Application of transcriptomics in Chinese herbal medicine studies. J. Tradit. Complement. Med. 2, 105–114. doi: 10.1016/S2225-4110(16)30083-9
Lu, S., Tran, B. N., Nelsen, J. L., and Aldous, K. M. (2009). Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 2499–2505. doi: 10.1016/j.jchromb.2009.06.024
Ma, L., Li, J., Qu, L., Hager, J., Chen, Z., Zhao, H., et al. (2001). Light control of Arabidopsis development entails coordinated regulation of genome expression and cellular pathways. Plant Cell 13, 2589–2607. doi: 10.1105/tpc.13.12.2589
Madala, N. E., Piater, L. A., Steenkamp, P. A., and Dubery, I. A. (2014). Multivariate statistical models of metabolomic data reveals different metabolite distribution patterns in isonitrosoacetophenone-elicited Nicotiana tabacum and Sorghum bicolor cells. Springerplus 3:254. doi: 10.1186/2193-1801-3-254
Marot, G., Foulley, J. L., Mayer, C. D., and Jaffrezic, F. (2009). Moderated effect size and P-value combinations for microarray meta-analyses. Bioinformatics 25, 2692–2699. doi: 10.1093/bioinformatics/btp444
Nakamura, S., Qu, Y., Xu, F., Matsuda, H., and Yoshikawa, M. (2008). Structures of new monoterpenes from Thai herbal medicine Curcuma comosa. Chem. Pharm. Bull. 56, 1604–1606. doi: 10.1248/cpb.56.1604
Nicholson, J. K., Lindon, J. C., and Holmes, E. (1999). “Metabonomics”: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181–1189. doi: 10.1080/004982599238047
Niu, W., Knight, E., Xia, Q., and McGarvey, B. D. (2014). Comparative evaluation of eight software programs for alignment of gas chromatography-mass spectrometry chromatograms in metabolomics experiments. J. Chromatogr. A 1374, 199–206. doi: 10.1016/j.chroma.2014.11.005
Padumanonda, T., Johns, J., Sangkasat, A., and Tiyaworanant, S. (2014). Determination of melatonin content in traditional Thai herbal remedies used as sleeping aids. Daru 22:6. doi: 10.1186/2008-2231-22-6
Phinney, K. W., Ballihaut, G., Bedner, M., Benford, B. S., Camara, J. E., Christopher, S. J., et al. (2013). Development of a standard reference material for metabolomics research. Anal. Chem. 85, 11732–11738. doi: 10.1021/ac402689t
Redestig, H., Fukushima, A., Stenlund, H., Moritz, T., Arita, M., Saito, K., et al. (2009). Compensation for systematic cross-contribution improves normalization of mass spectrometry based metabolomics data. Anal. Chem. 81, 7974–7980. doi: 10.1021/ac901143w
Sawasdee, P., Sabphon, C., Sitthiwongwanit, D., and Kokpol, U. (2009). Anticholinesterase activity of 7-methoxyflavones isolated from Kaempferia parviflora. Phytother. Res. 23, 1792–1794. doi: 10.1002/ptr.2858
Shimokawa, S., Kumamoto, T., Ishikawa, T., Takashi, M., Higuchi, Y., Chaichantipyuth, C., et al. (2013). Quantitative analysis of miroestrol and kwakhurin for standardisation of Thai miracle herb “Kwao Keur” (Pueraria mirifica) and establishment of simple isolation procedure for highly estrogenic miroestrol and deoxymiroestrol. Nat. Prod. Res. 27, 371–378. doi: 10.1080/14786419.2012.695370
Su, T., Tan, Y., Tsui, M. S., Yi, H., Fu, X. Q., Li, T., et al. (2016). Metabolomics reveals the mechanisms for the cardiotoxicity of Pinelliae Rhizoma and the toxicity-reducing effect of processing. Sci. Rep. 6:34692. doi: 10.1038/srep34692
Sutthanut, K., Sripanidkulchai, B., Yenjai, C., and Jay, M. (2007). Simultaneous identification and quantitation of 11 flavonoid constituents in Kaempferia parviflora by gas chromatography. J. Chromatogr. A 1143, 227–233. doi: 10.1016/j.chroma.2007.01.033
Swan, A. L., Stekel, D. J., Hodgman, C., Allaway, D., Algahtani, M. H., Mobasheri, A., et al. (2015). A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data. BMC Genomics 16:S2. doi: 10.1186/1471-2164-16-S1-S2
Sysi-Aho, M., Katajamaa, M., Yetukuri, L., and Oresic, M. (2007). Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinformatics 8:93. doi: 10.1186/1471-2105-8-93
Tautenhahn, R., Cho, K., Uritboonthai, W., Zhu, Z., Patti, G. J., and Siuzdak, G. (2012). An accelerated workflow for untargeted metabolomics using the METLIN database. Nat. Biotechnol. 30, 826–828. doi: 10.1038/nbt.2348
Thevenot, E. A., Roux, A., Xu, Y., Ezan, E., and Junot, C. (2015). Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J. Proteome Res. 14, 3322–3335. doi: 10.1021/acs.jproteome.5b00354
Thiengsusuk, A., Chaijaroenkul, W., and Na-Bangchang, K. (2013). Antimalarial activities of medicinal plants and herbal formulations used in Thai traditional medicine. Parasitol. Res. 112, 1475–1481. doi: 10.1007/s00436-013-3294-6
Tripatara, P., Onlamul, W., Booranasubkajorn, S., Wattanarangsan, J., Huabprasert, S., Lumlerdkij, N., et al. (2012). The safety of Homnawakod herbal formula containing Aristolochia tagala Cham. in Wistar rats. BMC Complement. Altern. Med. 12:170. doi: 10.1186/1472-6882-12-170
Tseng, G. C., Ghosh, D., and Feingold, E. (2012). Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Res. 40, 3785–3799. doi: 10.1093/nar/gkr1265
Vehlow, C., Kao, D. P., Bristow, M. R., Hunter, L. E., Weiskopf, D., and Gorg, C. (2015). Visual analysis of biological data-knowledge networks. BMC Bioinformatics 16:135. doi: 10.1186/s12859-015-0550-z
Villas-Bôas, S. G., Villas-Bôas, S. G., Roessner, U., Hansen, M. A. E., Smedsgaard, J., and Nielsen, J. (2006). “Sampling and sample preparation,” in Metabolome Analysis, ed D. M. Desiderio (Hoboken, NJ: John Wiley and Sons, Inc.), 39–82.
Vinaixa, M., Schymanski, E. L., Neumann, S., Navarro, M., Salek, R. M., and Yanes, O. (2016). Mass spectral databases for LC/MS- and GC/MS-based metabolomics: state of the field and future prospects. Trac Trends Anal. Chem. 78, 23–35. doi: 10.1016/j.trac.2015.09.005
Wikoff, W. R., Grapov, D., Fahrmann, J. F., DeFelice, B., Rom, W. N., Pass, H. I., et al. (2015). Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma. Cancer Prev. Res. 8, 410–418. doi: 10.1158/1940-6207.CAPR-14-0329
Xia, J., Fjell, C. D., Mayer, M. L., Pena, O. M., Wishart, D. S., and Hancock, R. E. (2013). INMEX–a web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res. 41, W63–W70. doi: 10.1093/nar/gkt338
Yang, Q., Sun, J., and Chen, Y. Q. (2016). Multi-dimensional, comprehensive sample extraction combined with LC-GC/MS analysis for complex biological samples: application in the metabolomics study of acute pancreatitis. RSC Adv. 6, 25837–25849. doi: 10.1039/C5RA26708K
Ye, X., Zhao, N., Yu, X., Han, X., Gao, H., and Zhang, X. (2016). Extensive characterization of peptides from Panax ginseng C. A. Meyer using mass spectrometric approach. Proteomics 16, 2788–2791. doi: 10.1002/pmic.201600183
Yin, X., Hiraga, S., Hajika, M., Nishimura, M., and Komatsu, S. (2017). Transcriptomic analysis reveals the flooding tolerant mechanism in flooding tolerant line and abscisic acid treated soybean. Plant Mol. Biol. 93, 479–496. doi: 10.1007/s11103-016-0576-2
Zhang, A., Sun, H., Dou, S., Sun, W., Wu, X., Wang, P., et al. (2013). Metabolomics study on the hepatoprotective effect of scoparone using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Analyst 138, 353–361. doi: 10.1039/C2AN36382H
Zhang, H. F., Yang, X. H., and Wang, Y. (2011). Microwave assisted extraction of secondary metabolites from plants: current status and future directions. Trends Food Sci. Technol. 22, 672–688. doi: 10.1016/j.tifs.2011.07.003
Zhang, Z., Lu, C., Liu, X., Su, J., Dai, W., Yan, S., et al. (2014). Global and targeted metabolomics reveal that Bupleurotoxin, a toxic type of polyacetylene, induces cerebral lesion by inhibiting GABA receptor in mice. J. Proteome Res. 13, 925–933. doi: 10.1021/pr400968c
Zhao, P., Li, J., Li, Y., Tian, Y., Yang, L., and Li, S. (2017). Integrating transcriptomics, proteomics, and metabolomics profiling with system pharmacology for the delineation of long-term therapeutic mechanisms of bufei jianpi formula in treating COPD. Biomed Res. Int. 2017:7091087. doi: 10.1155/2017/7091087
Keywords: metabolomics, analytical chemistry, herbal medicines, integrative omics, Thai traditional medicine
Citation: Khoomrung S, Wanichthanarak K, Nookaew I, Thamsermsang O, Seubnooch P, Laohapand T and Akarasereenont P (2017) Metabolomics and Integrative Omics for the Development of Thai Traditional Medicine. Front. Pharmacol. 8:474. doi: 10.3389/fphar.2017.00474
Received: 05 March 2017; Accepted: 03 July 2017;
Published: 18 July 2017.
Edited by:Adolfo Andrade-Cetto, National Autonomous University of Mexico, Mexico
Reviewed by:Liang Xiao, Second Military Medical University, China
Kannan R. R. Rengasamy, China Agricultural University, China
Copyright © 2017 Khoomrung, Wanichthanarak, Nookaew, Thamsermsang, Seubnooch, Laohapand and Akarasereenont. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.